Search Count: 27
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2019-01-23 Classification: CELL ADHESION |
 |
Dual Inhibition Of The Essential Protein Kinases A And B In Mycobacterium Tuberculosis
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:3.01 Å Release Date: 2018-02-14 Classification: TRANSFERASE/INHIBITOR Ligands: CJJ |
 |
Dual Inhibition Of The Essential Protein Kinases A And B In Mycobacterium Tuberculosis
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.88 Å Release Date: 2018-02-14 Classification: TRANSFERASE/INHIBITOR Ligands: CJJ, 0BD |
 |
Discovery Of Vx-509 (Decernotinib): A Potent And Selective Janus Kinase (Jak) 3 Inhibitor For The Treatment Of Autoimmune Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2015-08-12 Classification: Transferase/Transferase Inhibitor Ligands: 4HW |
 |
Discovery Of Vx-509 (Decernotinib): A Potent And Selective Janus Kinase (Jak) 3 Inhibitor For The Treatment Of Autoimmune Diseases
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.78 Å Release Date: 2015-08-12 Classification: Transferase/Transferase Inhibitor Ligands: 4HZ |
 |
Discovery Of Vx-509 (Decernotinib): A Potent And Selective Janus Kinase (Jak) 3 Inhibitor For The Treatment Of Autoimmune Diseases
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.04 Å Release Date: 2015-08-12 Classification: Transferase/Transferase Inhibitor Ligands: 467 |
 |
Discovery Of Vx-509 (Decernotinib): A Potent And Selective Janus Kinase (Jak) 3 Inhibitor For The Treatment Of Autoimmune Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.52 Å Release Date: 2015-08-12 Classification: Transferase/Transferase Inhibitor Ligands: VJK |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40W |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40Y, GOL |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40X, GOL |
 |
Discovery Of Novel Oxazepine And Diazepine Carboxamides As Two New Classes Of Heat Shock Protein 90 Inhibitors
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2015-03-04 Classification: Chaperone/chaperone Inhibitor Ligands: 40Z, GOL |
 |
Crystal Structure Of Nicotinate Mononucleotide Adenylyltransferase From Mycobacterium Tuberculosis
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.42 Å Release Date: 2015-01-28 Classification: TRANSFERASE Ligands: EPE, DMS |
 |
Structure Of M. Tuberculosis Nicotinate Mono Nucleotide Adenylyltransferase
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2015-01-28 Classification: TRANSFERASE Ligands: SO4, MES |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2014-12-24 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q8 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.79 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2Q9 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: FGH |
 |
Identification Of Novel Hsp90 / Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2R6 |
 |
Identification Of Novel Hsp90/Isoform Selective Inhibitors Using Structure-Based Drug Design. Demonstration Of Potential Utility In Treating Cns Disorders Such As Huntington'S Disease
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.93 Å Release Date: 2014-04-09 Classification: CHAPERONE/CHAPERONE INHIBITOR Ligands: 2QA |
 |
Correlation Between Chemotype-Dependent Binding Conformations Of Hsp90 Alpha/Beta And Isoform Selectivity
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.77 Å Release Date: 2014-01-22 Classification: CHAPERONE Ligands: 2LC |
 |
Correlation Between Chemotype-Dependent Binding Conformations Of Hsp90 Alpha/Beta And Isoform Selectivity
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2014-01-15 Classification: CHAPERONE Ligands: E0G, GOL |